Part No. |
Á¦Ç°¸í |
±æÀÌ
(§®) |
³»°æ
(§®) |
´ÜÀ§ |
°¡°Ý |
CH0-1751 |
OA-2000 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
4.0 |
ea |
|
CH0-1752 |
OA-2000 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
4.6 |
ea |
|
CH0-1754 |
OA-2000 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
10 |
ea |
|
CH0-1755 |
OA-2000 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
20 |
ea |
|
CH0-1758 |
OA-2000-1 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
4.6 |
ea |
|
CH0-1760 |
OA-2000-1 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
10 |
ea |
|
CH0-1761 |
OA-2000-1 (R)-Phenylglycine
& 3.5-dinitrobenzoic acid |
250 |
25 |
ea |
|
CH0-1763 |
OA-2200 (R) – Phenylglycine
& (1R,3R)-chrysanthemic acid |
250 |
4.0 |
ea |
|
CH0-1764 |
OA-2200 (R) – Phenylglycine
& (1R,3R)-chrysanthemic acid |
250 |
4.6 |
ea |
|
CH0-1770 |
OA-3100 (S) – valine
& 3.5-dinitroanaline |
250 |
4.6 |
ea |
|
CH0-1772 |
OA-3100 (S) – valine
& 3.5-dinitroanaline |
250 |
10 |
ea |
|
CH0-1773 |
OA-3100 (S) – valine
& 3.5-dinitroanaline |
250 |
20 |
ea |
|
CH0-1775 |
OA-3200 (S)-Tert-leucine
& 3,5-dinitroanaline |
250 |
4.0 |
ea |
|
CH0-1776 |
OA-3200 (S)-Tert-leucine
& 3,5-dinitroanaline |
250 |
4.6 |
ea |
|
CH0-1781 |
OA-3300 (R) – phenylglycine
& 3,5-dinitroanaline |
250 |
4.0 |
ea |
|
CH0-1782 |
OA-3300 (R) – phenylglycine
& 3,5-dinitroanaline |
250 |
4.6 |
ea |
|
CH0-1784 |
OA-3300 (R) – phenylglycine
& 3,5-dinitroanaline |
250 |
10 |
ea |
|
CH0-1785 |
OA-3300 (R) – phenylglycine
& 3,5-dinitroanaline |
250 |
20 |
ea |
|
CH0-1787 |
OA-4000 (S)-valine
& (S)-1-(¥á-naohthyl)-ethylamine |
250 |
4.0 |
ea |
|
CH0-1788 |
OA-4000 (S)-valine
& (S)-1-(¥á-naohthyl)-ethylamine |
250 |
4.6 |
ea |
|
CH0-1794 |
OA-4100 (S)-valine
& (S)-1-(¥á-naohthyl)-ethylamine |
250 |
4.6 |
ea |
|
CH0-1796 |
OA-4100 (S)-valine
& (S)-1-(¥á-naohthyl)-ethylamine |
250 |
10 |
ea |
|
CH0-1797 |
OA-4100 (S)-valine
& (S)-1-(¥á-naohthyl)-ethylamine |
250 |
20 |
ea |
|
CH0-1800 |
OA-4400 (S)-valine
& (R)-1-(¥á-naphthyl)-ethylamine |
250 |
4.6 |
ea |
|
CH0-1806 |
OA-4500 (S)-proline
& (R)-1-(¥á-naphthyl)-ethylamine |
250 |
4.6 |
ea |
|
CH0-1808 |
OA-4500 (S)-proline
& (R)-1-(¥á-naphthyl)-ethylamine |
250 |
10 |
ea |
|
CH0-1809 |
OA-4500 (S)-proline
& (R)-1-(¥á-naphthyl)-ethylamine |
250 |
20 |
ea |
|
CH0-1812 |
OA-4600 (S)-tert-leucine
& (S)-1-(¥á-naphtyl)-ethvamine |
250 |
4.6 |
ea |
|
CH0-1818 |
OA-4700 (S)-tert-leucine
& (R)-1-(¥á-naphtyl)-ethvamine |
250 |
4.6 |
ea |
|
CH0-1820 |
OA-4700 (S)-tert-leucine
& (R)-1-(¥á-naphtyl)-ethvamine |
250 |
10 |
ea |
|
CH0-1821 |
OA-4700 (S)-tert-leucine
& (R)-1-(¥á-naphtyl)-ethvamine |
250 |
20 |
ea |
|
CH0-1823 |
OA-4800
(S)-indoline-2-carboxyic acid
& (S)-1-(¥á-naphthyl)ethylamine |
250 |
4.0 |
ea |
|
CH0-1824 |
OA-4800
(S)-indoline-2-carboxyic acid
& (S)-1-(¥á-naphthyl)ethylamine |
250 |
4.6 |
ea |
|
CH0-1830 |
OA-4900
(S)-indoline-2-carboxyic acid
& (R)-1-(¥á-naphthyl)ethylamine |
250 |
4.6 |
ea |
|
CH0-1832 |
OA-4900
(S)-indoline-2-carboxyic acid & (R)-1-(¥á-naphthyl)ethylamine |
250 |
10 |
ea |
|
CH0-1833 |
OA-4900
(S)-indoline-2-carboxyic acid & (R)-1-(¥á-naphthyl)ethylamine |
250 |
20 |
ea |
|
CH0-1835 |
OA-2500 (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
4.0 |
ea |
|
CH0-1836 |
OA-2500 (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
4.6 |
ea |
|
CH0-1838 |
OA-2500 (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
10 |
ea |
|
CH0-1839 |
OA-2500 (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
20 |
ea |
|
CH0-1848 |
OA-2500-I (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
4.6 |
ea |
|
CH0-1850 |
OA-2500-I (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
10 |
ea |
|
CH0-1851 |
OA-2500-I (R)-1-naphthlglycine
& 3.5-dinitrobenzoic acid |
250 |
20 |
ea |
|
CH0-1859 |
OA-5000 (D)-penicillamine |
150 |
4.6 |
ea |
|
CH0-1861 |
OA-5500 Chiral Schiff base |
150 |
4.6 |
ea |
|
CH0-1863 |
OA-6100
(L)-tartaric acid-mono-(L)-valine-(S)-1-(¥á-naphthyl) ethylamide |
150 |
4.6 |
ea |
|
CH0-5649 |
OA-7000
©¬-Cyclodextrin(derivatized) |
250 |
4.6 |
ea |
|
CH0-7050 |
Crown ether |
150 |
4.6 |
ea |
|